Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Tashiro

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Acta Histochemica Et Cytochemica|July 9, 2025
Impact of circ<i>PVT1</i> Expression on Prostate Cancer Malignancy and Tumor GrowthMiyaka Umemori, Kojiro Tashiro, Ayana Horiguchi, et al.
Acta Histochemica Et Cytochemica|July 9, 2025
Impact of circ<i>PVT1</i> Expression on Prostate Cancer Malignancy and Tumor GrowthMiyaka Umemori, Kojiro Tashiro, Ayana Horiguchi, et al.
IJU Case Reports|November 10, 2021
Knotted ureteral single-J stent in a patient with ureterocutaneostomyYuhei Koike, Fumihiko Urabe, Kosuke Iwatani, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 18, 2026
Real-World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate CancerHidetsugu Takahashi, Wataru Fukuokaya, Katsuki Muramoto, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2021
Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysisFumihiko Urabe, Shoji Kimura, Kojiro Tashiro, et al.
Prostate International|September 25, 2023
Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomyKoichi Aikawa, Shoji Kimura, Fumihiko Urabe, et al.
International Journal of Clinical Oncology|October 22, 2021
Prognostic value of PSA bounce after definitive radiotherapy revisitedFumihiko Urabe, Takahiro Kimura, Hiroshi Sasaki, et al.
European Urology Open Science|July 11, 2026
Large-scale Genomic Landscape and Clinical Outcomes of De Novo and Treatment-emergent Neuroendocrine Prostate CancerKazuki Iida, Kojiro Tashiro, Fumihiko Urabe, et al.
NPJ Precision Oncology|February 26, 2026
Genomic landscape and clinical impact of BRCA1/2 pathogenic variants in metastatic castration-resistant prostate cancerKazuki Iida, Fumihiko Urabe, Yuya Matsui, et al.
Journal of Clinical Pharmacology|December 9, 2022
A Phase II Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- and Chemotherapy-Naïve Patients With Castration-Resistant Prostate CancerMasaki Shiota, Ryo Inoue, Kojiro Tashiro, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Acta Histochemica Et Cytochemica|July 9, 2025
Impact of circ<i>PVT1</i> Expression on Prostate Cancer Malignancy and Tumor GrowthMiyaka Umemori, Kojiro Tashiro, Ayana Horiguchi, et al.
Acta Histochemica Et Cytochemica|July 9, 2025
Impact of circ<i>PVT1</i> Expression on Prostate Cancer Malignancy and Tumor GrowthMiyaka Umemori, Kojiro Tashiro, Ayana Horiguchi, et al.
IJU Case Reports|November 10, 2021
Knotted ureteral single-J stent in a patient with ureterocutaneostomyYuhei Koike, Fumihiko Urabe, Kosuke Iwatani, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 18, 2026
Real-World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate CancerHidetsugu Takahashi, Wataru Fukuokaya, Katsuki Muramoto, et al.
Prostate Cancer and Prostatic Diseases|May 5, 2021
Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysisFumihiko Urabe, Shoji Kimura, Kojiro Tashiro, et al.
Prostate International|September 25, 2023
Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomyKoichi Aikawa, Shoji Kimura, Fumihiko Urabe, et al.
International Journal of Clinical Oncology|October 22, 2021
Prognostic value of PSA bounce after definitive radiotherapy revisitedFumihiko Urabe, Takahiro Kimura, Hiroshi Sasaki, et al.
European Urology Open Science|July 11, 2026
Large-scale Genomic Landscape and Clinical Outcomes of De Novo and Treatment-emergent Neuroendocrine Prostate CancerKazuki Iida, Kojiro Tashiro, Fumihiko Urabe, et al.
NPJ Precision Oncology|February 26, 2026
Genomic landscape and clinical impact of BRCA1/2 pathogenic variants in metastatic castration-resistant prostate cancerKazuki Iida, Fumihiko Urabe, Yuya Matsui, et al.
Journal of Clinical Pharmacology|December 9, 2022
A Phase II Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- and Chemotherapy-Naïve Patients With Castration-Resistant Prostate CancerMasaki Shiota, Ryo Inoue, Kojiro Tashiro, et al.
Pageof 10